speb/financial-data huggingface dataset:
BBIO balance_sheet (quarterly, 2025-09-30) — Work In Process: 4132000.00
BBIO balance_sheet (quarterly, 2025-09-30) — Working Capital: 622782000.00
BBIO income_statement (annual, 2025-12-31) — +Operating Expense: 983178000.00
BBIO income_statement (quarterly, 2025-12-31) — +Operating Expense: 274502000.00
BBIO income_statement (annual, 2025-12-31) — +Total Revenue: 502076000.00
BBIO income_statement (quarterly, 2025-12-31) — +Total Revenue: 154178000.00
BBIO balance_sheet (annual, 2025-12-31) — Accounts Payable: 36228000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 36228000.00
BBIO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 139444000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 139444000.00
BBIO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2057646000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2057646000.00
BBIO income_statement (annual, 2025-12-31) — Basic Average Shares: 191527482.00
BBIO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 193552280.00
BBIO income_statement (annual, 2025-12-31) — Basic EPS: -3.78
BBIO income_statement (quarterly, 2025-12-31) — Basic EPS: -1.00
BBIO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 683244000.00
BBIO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 645096000.00
BBIO cash_flow (annual, 2025-12-31) — Capital Expenditure: -9592000.00
BBIO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -33000.00
BBIO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 10003000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 10003000.00
BBIO balance_sheet (annual, 2025-12-31) — Capital Stock: 202000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 202000.00
BBIO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 570119000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 570119000.00
BBIO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 587482000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 587482000.00
BBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 359293000.00
BBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2182000.00
BBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -24487000.00
BBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -14354000.00
BBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -445910000.00
BBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -56420000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Account Payable: 26609000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 17525000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 30185000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 26626000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Inventory: -25307000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -1951000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 1113000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 545000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -6547000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -54820000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 66382000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 75862000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Payable: 26609000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Payable: 17525000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 56794000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 44151000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -8777000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 8750000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Receivables: -134722000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -22926000.00
BBIO cash_flow (annual, 2025-12-31) — Change In Working Capital: -51064000.00
BBIO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 49611000.00
BBIO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -134722000.00
BBIO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -22926000.00
BBIO cash_flow (annual, 2025-12-31) — Changes In Cash: -111104000.00
BBIO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -72956000.00
BBIO balance_sheet (annual, 2025-12-31) — Common Stock: 202000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Common Stock: 202000.00
BBIO balance_sheet (annual, 2025-12-31) — Common Stock Equity: -2086610000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -2086610000.00
BBIO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
BBIO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
BBIO cash_flow (annual, 2025-12-31) — Common Stock Payments: -62502000.00
BBIO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -7430000.00
BBIO income_statement (annual, 2025-12-31) — Cost Of Revenue: 20962000.00
BBIO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 8107000.00
BBIO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 150437000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 150437000.00
BBIO balance_sheet (annual, 2025-12-31) — Current Assets: 797749000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Current Assets: 797749000.00
BBIO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 6192000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 6192000.00
BBIO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6192000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6192000.00
BBIO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 18411000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 18411000.00
BBIO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 7190000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 7190000.00
BBIO balance_sheet (annual, 2025-12-31) — Current Liabilities: 287971000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 287971000.00
BBIO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5434000.00
BBIO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1435000.00
BBIO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5434000.00
BBIO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1435000.00
BBIO income_statement (annual, 2025-12-31) — Diluted Average Shares: 191527482.00
BBIO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 193552280.00
BBIO income_statement (annual, 2025-12-31) — Diluted EPS: -3.78
BBIO income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.00
BBIO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -724931000.00
BBIO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -192863000.00
BBIO cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 2302000.00
BBIO cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 0.00
BBIO income_statement (annual, 2025-12-31) — EBIT: -554262000.00
BBIO income_statement (quarterly, 2025-12-31) — EBIT: -144441000.00
BBIO income_statement (annual, 2025-12-31) — EBITDA: -548828000.00
BBIO income_statement (quarterly, 2025-12-31) — EBITDA: -143006000.00
BBIO income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -72608000.00
BBIO income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -21029000.00
BBIO cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 72608000.00
BBIO cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 28798000.00
BBIO cash_flow (annual, 2025-12-31) — End Cash Position: 572140000.00
BBIO cash_flow (quarterly, 2025-12-31) — End Cash Position: 572140000.00
BBIO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 359293000.00
BBIO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2182000.00
BBIO cash_flow (annual, 2025-12-31) — Free Cash Flow: -455502000.00
BBIO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -56453000.00
BBIO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -8833000.00
BBIO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 2229000.00
BBIO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
BBIO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
BBIO income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 0.00
BBIO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
BBIO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 12000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 12000.00
BBIO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 28077000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 28077000.00
BBIO balance_sheet (annual, 2025-12-31) — Gross PPE: 13515000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 13515000.00
BBIO income_statement (annual, 2025-12-31) — Gross Profit: 481114000.00
BBIO income_statement (quarterly, 2025-12-31) — Gross Profit: 146071000.00
BBIO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
BBIO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
BBIO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1198000.00
BBIO income_statement (annual, 2025-12-31) — Interest Expense: 178241000.00
BBIO income_statement (quarterly, 2025-12-31) — Interest Expense: 50314000.00
BBIO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 178241000.00
BBIO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 50314000.00
BBIO income_statement (annual, 2025-12-31) — Interest Income: 19854000.00
BBIO income_statement (quarterly, 2025-12-31) — Interest Income: 4332000.00
BBIO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 19854000.00
BBIO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 4332000.00
BBIO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 43760000.00
BBIO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 90000.00
BBIO balance_sheet (annual, 2025-12-31) — Interest Payable: 14411000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Interest Payable: 14411000.00
BBIO balance_sheet (annual, 2025-12-31) — Inventory: 26753000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Inventory: 26753000.00
BBIO balance_sheet (annual, 2025-12-31) — Invested Capital: -234140000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: -234140000.00
BBIO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -24487000.00
BBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -14354000.00
BBIO balance_sheet (annual, 2025-12-31) — Investments And Advances: 79972000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 79972000.00
BBIO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
BBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
BBIO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 575000000.00
BBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
BBIO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3811000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3811000.00
BBIO balance_sheet (annual, 2025-12-31) — Long Term Debt: 1852470000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1852470000.00
BBIO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1856281000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1856281000.00
BBIO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 575000000.00
BBIO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
BBIO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -459000000.00
BBIO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
BBIO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 79972000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 79972000.00
BBIO balance_sheet (annual, 2025-12-31) — Minority Interest: 10029000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 10029000.00
BBIO income_statement (annual, 2025-12-31) — Minority Interests: 8007000.00
BBIO income_statement (quarterly, 2025-12-31) — Minority Interests: 1772000.00
BBIO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
BBIO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -62502000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -7430000.00
BBIO balance_sheet (annual, 2025-12-31) — Net Debt: 1282351000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Net Debt: 1282351000.00
BBIO income_statement (annual, 2025-12-31) — Net Income: -724931000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Income: -192863000.00
BBIO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -724931000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -192863000.00
BBIO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -732938000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -194635000.00
BBIO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -724931000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -192863000.00
BBIO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -724931000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -192863000.00
BBIO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -732938000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -194635000.00
BBIO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -732938000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -194635000.00
BBIO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -8495000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
BBIO income_statement (annual, 2025-12-31) — Net Interest Income: -158387000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Interest Income: -45982000.00
BBIO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -17197000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -14321000.00
BBIO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 116000000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BBIO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 116000000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BBIO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -158387000.00
BBIO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -45982000.00
BBIO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 271646000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -7964000.00
BBIO balance_sheet (annual, 2025-12-31) — Net PPE: 13515000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 13515000.00
BBIO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1097000.00
BBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -33000.00
BBIO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -2114687000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -2114687000.00
BBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 868110000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 868110000.00
BBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 13080000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 13080000.00
BBIO income_statement (annual, 2025-12-31) — Normalized EBITDA: -506326000.00
BBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -100635000.00
BBIO income_statement (annual, 2025-12-31) — Normalized Income: -691354420.00
BBIO income_statement (quarterly, 2025-12-31) — Normalized Income: -150518107.26
BBIO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -445910000.00
BBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -56420000.00
BBIO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 84930000.00
BBIO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 31027000.00
BBIO income_statement (annual, 2025-12-31) — Operating Income: -502064000.00
BBIO income_statement (quarterly, 2025-12-31) — Operating Income: -128431000.00
BBIO income_statement (annual, 2025-12-31) — Operating Revenue: 502076000.00
BBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: 154178000.00
BBIO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 194771957.00
BBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 194771957.00
BBIO balance_sheet (annual, 2025-12-31) — Other Current Assets: 44070000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 44070000.00
BBIO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 12000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 12000.00
BBIO income_statement (annual, 2025-12-31) — Other Income Expense: -72052000.00
BBIO income_statement (quarterly, 2025-12-31) — Other Income Expense: -20342000.00
BBIO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 136007000.00
BBIO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 42806000.00
BBIO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 16712000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 16712000.00
BBIO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 244000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 244000.00
BBIO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 43058000.00
BBIO balance_sheet (annual, 2025-12-31) — Other Properties: 13515000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Other Properties: 13515000.00
BBIO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 17363000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 17363000.00
BBIO income_statement (annual, 2025-12-31) — Other Special Charges: 21155000.00
BBIO income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
BBIO balance_sheet (annual, 2025-12-31) — Payables: 36228000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Payables: 36228000.00
BBIO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 186665000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 186665000.00
BBIO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 76703000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 76703000.00
BBIO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BBIO income_statement (annual, 2025-12-31) — Pretax Income: -732503000.00
BBIO income_statement (quarterly, 2025-12-31) — Pretax Income: -194755000.00
BBIO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 34149000.00
BBIO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 13212000.00
BBIO cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
BBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
BBIO cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -8495000.00
BBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: 0.00
BBIO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -28197000.00
BBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -17321000.00
BBIO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1097000.00
BBIO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -33000.00
BBIO balance_sheet (annual, 2025-12-31) — Receivables: 139444000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Receivables: 139444000.00
BBIO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 20962000.00
BBIO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 8107000.00
BBIO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 5434000.00
BBIO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1435000.00
BBIO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -459000000.00
BBIO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
BBIO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -62502000.00
BBIO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -7430000.00
BBIO income_statement (annual, 2025-12-31) — Research And Development: 451953000.00
BBIO income_statement (quarterly, 2025-12-31) — Research And Development: 116417000.00
BBIO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 21347000.00
BBIO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 11131000.00
BBIO balance_sheet (annual, 2025-12-31) — Retained Earnings: -3821194000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -3821194000.00
BBIO cash_flow (annual, 2025-12-31) — Sale Of Investment: 11000000.00
BBIO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 3000000.00
BBIO income_statement (annual, 2025-12-31) — Selling General And Administration: 531225000.00
BBIO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 158085000.00
BBIO balance_sheet (annual, 2025-12-31) — Share Issued: 202369129.00
BBIO balance_sheet (quarterly, 2025-12-31) — Share Issued: 202369129.00
BBIO income_statement (annual, 2025-12-31) — Special Income Charges: -42502000.00
BBIO income_statement (quarterly, 2025-12-31) — Special Income Charges: -42371000.00
BBIO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 133024000.00
BBIO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 34639000.00
BBIO balance_sheet (annual, 2025-12-31) — Stockholders Equity: -2086610000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -2086610000.00
BBIO balance_sheet (annual, 2025-12-31) — Tangible Book Value: -2114687000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -2114687000.00
BBIO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -8925420.00
BBIO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -26107.26
BBIO income_statement (annual, 2025-12-31) — Tax Provision: 435000.00
BBIO income_statement (quarterly, 2025-12-31) — Tax Provision: -120000.00
BBIO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
BBIO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BBIO balance_sheet (annual, 2025-12-31) — Total Assets: 936025000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Total Assets: 936025000.00
BBIO balance_sheet (annual, 2025-12-31) — Total Capitalization: -234140000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -234140000.00
BBIO balance_sheet (annual, 2025-12-31) — Total Debt: 1862473000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Total Debt: 1862473000.00
BBIO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -2076581000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -2076581000.00
BBIO income_statement (annual, 2025-12-31) — Total Expenses: 1004140000.00
BBIO income_statement (quarterly, 2025-12-31) — Total Expenses: 282609000.00
BBIO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3012606000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3012606000.00
BBIO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 138276000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 138276000.00
BBIO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2724635000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2724635000.00
BBIO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -523411000.00
BBIO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -139562000.00
BBIO income_statement (annual, 2025-12-31) — Total Unusual Items: -42502000.00
BBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -42371000.00
BBIO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -42502000.00
BBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -42371000.00
BBIO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 7597172.00
BBIO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 7597172.00
BBIO balance_sheet (annual, 2025-12-31) — Treasury Stock: 323276000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 323276000.00
BBIO cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -21303000.00
BBIO balance_sheet (annual, 2025-12-31) — Working Capital: 509778000.00
BBIO balance_sheet (quarterly, 2025-12-31) — Working Capital: 509778000.00
BBIO income_statement (quarterly, 2026-03-31) — +Operating Expense: 290532000.00
BBIO income_statement (quarterly, 2026-03-31) — +Total Revenue: 194515000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 29058000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 205226000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2112454000.00
BBIO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 194789897.00
BBIO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.84
BBIO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 572140000.00
BBIO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -69000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 18655000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 204000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 879891000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 940186000.00
BBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 549892000.00
BBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -42735000.00
BBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -197279000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -7170000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -24482000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -7053000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -1795000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 2765000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -2379000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Payable: -7170000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -31652000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -18845000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -65782000.00
BBIO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -124741000.00
BBIO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -65782000.00
BBIO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 309878000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Common Stock: 204000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -2278363000.00
BBIO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -86574000.00
BBIO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 9939000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 168451000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Assets: 1241306000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4439000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Debt: 547483000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 551922000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 27603000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 6115000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 816372000.00
BBIO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1186000.00
BBIO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1186000.00
BBIO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 194789897.00
BBIO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.84
BBIO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -164043000.00
BBIO income_statement (quarterly, 2026-03-31) — EBIT: -113740000.00
BBIO income_statement (quarterly, 2026-03-31) — EBITDA: -112554000.00
BBIO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -18283000.00
BBIO cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 18283000.00
BBIO cash_flow (quarterly, 2026-03-31) — End Cash Position: 882018000.00
BBIO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 549892000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 8037000.00
BBIO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -197348000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -8000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 27359000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 22167000.00
BBIO income_statement (quarterly, 2026-03-31) — Gross Profit: 184576000.00
BBIO income_statement (quarterly, 2026-03-31) — Interest Expense: 52815000.00
BBIO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 52815000.00
BBIO income_statement (quarterly, 2026-03-31) — Interest Income: 6246000.00
BBIO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 6246000.00
BBIO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 20316000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Interest Payable: 5188000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -1331000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Inventory: 32980000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 195198000.00
BBIO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -42735000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 61529000.00
BBIO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 632500000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 14216000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1926078000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1940294000.00
BBIO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 632500000.00
BBIO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
BBIO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 61529000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 9488000.00
BBIO income_statement (quarterly, 2026-03-31) — Minority Interests: 2512000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -86574000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Net Debt: 1593670000.00
BBIO income_statement (quarterly, 2026-03-31) — Net Income: -164043000.00
BBIO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -164043000.00
BBIO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -166555000.00
BBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -164043000.00
BBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -164043000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -166555000.00
BBIO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -166555000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
BBIO income_statement (quarterly, 2026-03-31) — Net Interest Income: -46569000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -42666000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 632500000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 632500000.00
BBIO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -46569000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -24089000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Net PPE: 22167000.00
BBIO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -69000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -2305722000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 882961000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 11776000.00
BBIO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -112554000.00
BBIO income_statement (quarterly, 2026-03-31) — Normalized Income: -164043000.00
BBIO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -197279000.00
BBIO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 18283000.00
BBIO income_statement (quarterly, 2026-03-31) — Operating Income: -105956000.00
BBIO income_statement (quarterly, 2026-03-31) — Operating Revenue: 194515000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 195707702.00
BBIO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 62914000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 547483000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -8000.00
BBIO income_statement (quarterly, 2026-03-31) — Other Income Expense: -14030000.00
BBIO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 43158000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 18620000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 229000.00
BBIO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 4253000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Other Properties: 22167000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 60295000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Payables: 29058000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 197509000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 39338000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BBIO income_statement (quarterly, 2026-03-31) — Pretax Income: -166555000.00
BBIO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 28055000.00
BBIO cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: 0.00
BBIO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -52666000.00
BBIO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -69000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 15789000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Receivables: 205226000.00
BBIO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 9939000.00
BBIO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1186000.00
BBIO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
BBIO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -86574000.00
BBIO income_statement (quarterly, 2026-03-31) — Research And Development: 126636000.00
BBIO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
BBIO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -3985237000.00
BBIO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 10000000.00
BBIO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 163896000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Share Issued: 204386699.00
BBIO income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
BBIO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 33242000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -2278363000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -2305722000.00
BBIO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BBIO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
BBIO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1370981000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -352285000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Total Debt: 2492216000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -2268875000.00
BBIO income_statement (quarterly, 2026-03-31) — Total Expenses: 300471000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3639856000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 129675000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2823484000.00
BBIO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -105956000.00
BBIO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
BBIO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BBIO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 8678997.00
BBIO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 405776000.00
BBIO cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -1852000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Work In Process: 10485000.00
BBIO balance_sheet (quarterly, 2026-03-31) — Working Capital: 424934000.00
BBK.DE cash_flow (annual, 2021-12-31) — Capital Expenditure: -442000000.00
BBK.DE balance_sheet (annual, 2021-12-31) — Current Notes Payable: 808000000.00
BBK.DE income_statement (annual, 2021-12-31) — Depreciation Income Statement: 190000000.00
BBK.DE income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 37000000.00
BBK.DE cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
BBK.DE cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -442000000.00
BBK.DE cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
BBK.DE cash_flow (annual, 2021-12-31) — Purchase Of PPE: -442000000.00
BBK.DE income_statement (annual, 2022-12-31) — +Total Revenue: 19973000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2682000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2528000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 34544000000.00
BBK.DE income_statement (annual, 2022-12-31) — Amortization: 455000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 583000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 583000000.00
BBK.DE income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 455000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
BBK.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 898000000.00
BBK.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 1328120000.00
BBK.DE income_statement (annual, 2022-12-31) — Basic EPS: 4.46
BBK.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 20295000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2474000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -564000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 13307000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 21421000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 24602000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2989000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Cash Financial: 5379000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 20017000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -29972000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 11081000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 54000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 2452000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: 4985000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Changes In Cash: 1126000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Common Stock: 6634000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2656000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 53841000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: -250000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Construction In Progress: 211000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Current Debt: 19743000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 19743000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Current Notes Payable: 370000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 4539000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Depreciation: 783000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1366000000.00
BBK.DE income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 639000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1366000000.00
BBK.DE income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 639000000.00
BBK.DE income_statement (annual, 2022-12-31) — Depreciation Income Statement: 184000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 1551000000.00
BBK.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 1338462000.00
BBK.DE income_statement (annual, 2022-12-31) — Diluted EPS: 4.43
BBK.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 5927000000.00
BBK.DE cash_flow (annual, 2022-12-31) — End Cash Position: 21421000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: 20017000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 11081000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 71000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
BBK.DE income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -71000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -13601000000.00
BBK.DE income_statement (annual, 2022-12-31) — General And Administrative Expense: 6558000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Goodwill: 27013000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 34443000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 9408000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 57713000000.00
BBK.DE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
BBK.DE cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 479000000.00
BBK.DE income_statement (annual, 2022-12-31) — Interest Expense: 2321000000.00
BBK.DE income_statement (annual, 2022-12-31) — Interest Income: 16634000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2007000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 116787000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -29972000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Investments And Advances: 133357000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
BBK.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 15777000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Land And Improvements: 777000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Leases: 928000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 43203000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 43203000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 15777000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -7297000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1706000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Minority Interest: 23000000.00
BBK.DE income_statement (annual, 2022-12-31) — Minority Interests: -7000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -4673000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -250000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Net Debt: 41525000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Income: 6260000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 5927000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 5779000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 488000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6260000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 5772000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6267000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6267000000.00
BBK.DE income_statement (annual, 2022-12-31) — Net Interest Income: 14313000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 8376000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 26540000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 8480000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -298000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1682000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Net PPE: 6880000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -564000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
BBK.DE cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 18060000000.00
BBK.DE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 26071000000.00
BBK.DE income_statement (annual, 2022-12-31) — Normalized Income: 6155052000.00
BBK.DE income_statement (annual, 2022-12-31) — Occupancy And Equipment: 1139000000.00
BBK.DE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 11081000000.00